Comprehensive Information & Analysis Report on Portable Lung Monitors Market - 2021 to 2028
The "Global Portable Lung Monitors Market" is predicted to reach at a high CAGR during the forecast period (2021-2028)
(EMAILWIRE.COM, October 05, 2021 )
Market Overview
Portable Lung monitors are devices that provide medication to prevent and handle signs and assistance reduce worsenings of several lung conditions such as persistent obstructive lung illness (COPD) and asthma.
Lung monitoring devices might consist of either a single or a mix of drugs, such as a bronchodilator, a corticosteroid, a mix of various bronchodilators, or corticosteroids, respectively.
View full report: https://bit.ly/3Ab3i8K
Market Dynamics
The portable lung monitors market growth is driven by the increasing infectious disease related to lungs, decrease in lungs oxygen holding capacity, high patient chronic disease related to lungs like (asthma, pneumonia).
The increasing prevalence of chronic respiratory diseases, is expected to drive the growth in the forecast period
The major respiratory disorders currently cured using Portable Lung Monitors include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases.
As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had the chronic obstructive pulmonary disease (COPD) in 2018.
Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.
The high cost of lung monitors is likely to hamper the market growth
The high cost of lung monitors $2,070, the recurring cost of operation of $735 is likely to hinder the market growth.
Segmentation
By Product Type
Wearable respiratory monitoring
Respiratory Rate Monitoring
Blood Oxygen Monitoring
Other Monitoring
By Application
Asthma
Chronic obstructive pulmonary disease
Infectious Diseases
Others
By End-User
Hospital
Clinic
Household
Other
Download free sample: https://bit.ly/3DcA0IN
Geographical Analysis
North America region holds the largest market share of the global portable lung monitors market
The U.S. is one of the largest markets for portable lung monitors globally. The U.S. is the hub of medical devices. This market is set to grow with the high pitch in the forecast period due to continuous research in this field in the U.S., making it a most lucrative market.
Due high prevalence of lung disorders like COVID-19, asthma, bronchitis, pneumonia, chronic obstructive pulmonary disease, COPD, this factor is the key driver of the Portable Lung Monitors market. Around 35 Mn Americans have chronic lung disease, As per American Lung Association. Among all lung diseases in the U.S., asthma is most common, 25 Mn, followed by interstitial lung disease 12 Mn and chronic obstructive pulmonary disease (COPD) 11 Mn.
Competitive Landscape
The global portable lung monitors market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include GE Healthcare, Philips Healthcare, Medtronic, ResMed, Siemens Healthcare, Merck & Co., Calando Pharmaceuticals, Quark Pharmaceuticals, Sirnaomics Inc, Traversa Therapeutics.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in May 2021 Siemens accelerates digital marketplace strategy with the acquisition of a Supply frame.
Related Topic's
Lung Cancer Surgery Market, Acute Lung Injury Market, Airway Stent Lung Stent Market, Artificial-Heart Lung Machine Market, Squamous Non-Small Cell Lung Cancer Therapeutics Market
Market Overview
Portable Lung monitors are devices that provide medication to prevent and handle signs and assistance reduce worsenings of several lung conditions such as persistent obstructive lung illness (COPD) and asthma.
Lung monitoring devices might consist of either a single or a mix of drugs, such as a bronchodilator, a corticosteroid, a mix of various bronchodilators, or corticosteroids, respectively.
View full report: https://bit.ly/3Ab3i8K
Market Dynamics
The portable lung monitors market growth is driven by the increasing infectious disease related to lungs, decrease in lungs oxygen holding capacity, high patient chronic disease related to lungs like (asthma, pneumonia).
The increasing prevalence of chronic respiratory diseases, is expected to drive the growth in the forecast period
The major respiratory disorders currently cured using Portable Lung Monitors include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases.
As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had the chronic obstructive pulmonary disease (COPD) in 2018.
Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.
The high cost of lung monitors is likely to hamper the market growth
The high cost of lung monitors $2,070, the recurring cost of operation of $735 is likely to hinder the market growth.
Segmentation
By Product Type
Wearable respiratory monitoring
Respiratory Rate Monitoring
Blood Oxygen Monitoring
Other Monitoring
By Application
Asthma
Chronic obstructive pulmonary disease
Infectious Diseases
Others
By End-User
Hospital
Clinic
Household
Other
Download free sample: https://bit.ly/3DcA0IN
Geographical Analysis
North America region holds the largest market share of the global portable lung monitors market
The U.S. is one of the largest markets for portable lung monitors globally. The U.S. is the hub of medical devices. This market is set to grow with the high pitch in the forecast period due to continuous research in this field in the U.S., making it a most lucrative market.
Due high prevalence of lung disorders like COVID-19, asthma, bronchitis, pneumonia, chronic obstructive pulmonary disease, COPD, this factor is the key driver of the Portable Lung Monitors market. Around 35 Mn Americans have chronic lung disease, As per American Lung Association. Among all lung diseases in the U.S., asthma is most common, 25 Mn, followed by interstitial lung disease 12 Mn and chronic obstructive pulmonary disease (COPD) 11 Mn.
Competitive Landscape
The global portable lung monitors market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include GE Healthcare, Philips Healthcare, Medtronic, ResMed, Siemens Healthcare, Merck & Co., Calando Pharmaceuticals, Quark Pharmaceuticals, Sirnaomics Inc, Traversa Therapeutics.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in May 2021 Siemens accelerates digital marketplace strategy with the acquisition of a Supply frame.
Related Topic's
Lung Cancer Surgery Market, Acute Lung Injury Market, Airway Stent Lung Stent Market, Artificial-Heart Lung Machine Market, Squamous Non-Small Cell Lung Cancer Therapeutics Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results